PDF herunterladen
Hamostaseologie 2020; 40(S 01): S21-S25
DOI: 10.1055/a-1282-1989
Original Article

Flow Cytometric Assessment of AKT Signaling in Platelet Activation: An Alternative Diagnostic Tool for Small Volumes of Blood

K. Althaus
1   Transfusion Medicine, Medical Faculty of Tuebingen, University Hospital of Tuebingen, Tuebingen, Germany
2   Centre for Clinical Transfusion Medicine, University Hospital of Tuebingen, Tuebingen, Germany
,
M. Wagner
1   Transfusion Medicine, Medical Faculty of Tuebingen, University Hospital of Tuebingen, Tuebingen, Germany
,
I. Marini
1   Transfusion Medicine, Medical Faculty of Tuebingen, University Hospital of Tuebingen, Tuebingen, Germany
,
T. Bakchoul
1   Transfusion Medicine, Medical Faculty of Tuebingen, University Hospital of Tuebingen, Tuebingen, Germany
2   Centre for Clinical Transfusion Medicine, University Hospital of Tuebingen, Tuebingen, Germany
,
L. Pelzl
1   Transfusion Medicine, Medical Faculty of Tuebingen, University Hospital of Tuebingen, Tuebingen, Germany
› Institutsangaben
› Weitere Informationen
Auch verfügbar auf
   Lizenzen und Reprints

Abstract

Introduction The diagnosis of platelet function disorder in children is challenging. Light transmission aggregometry is the gold standard for platelet function disorders. However, large blood volumes are required. Currently, there are no existing tools for the diagnosis of platelet function disorders that use small blood volumes. AKT signaling plays a central role in platelet activation during hemostasis and might be visualized by flow cytometry.

Methods Platelet-rich plasma obtained by centrifugation of citrated blood from healthy volunteers was activated with arachidonic acid, thrombin receptor activating peptide-6 (TRAP-6), collagen, adenosine diphosphate ADP, collagen-related peptide (CRP), and epinephrine. After platelet activation, the phosphorylation of AKT was assessed by flow cytometer using a Navios cytometer.

Results Healthy volunteers showed a reproducible phosphorylation of AKT upon activation. In comparison to nonactivated platelets, we documented an increase in pAKT expression with all agonists. Especially TRAP-6 and CRP caused considerable increase in percentage of pAKT expression throughout all the tested healthy volunteers.

Conclusion An activation of the AKT-signal pathway by different agonists can clearly be detected on the flow cytometer, indicating that the visualization of signaling in platelets by flow cytometry might be an efficient alternative for light transmission aggregometry to test platelet function in children.

Keywords

AKT - platelet - acquired platelet disorders - inherited platelet disorders - platelet function

Authors' Contribution

K.A., M.W., and T.B. designed the study; M.W., L.P., and I.M. performed the experiments. L.P., M.W., T.B. and K.A. collected and analyzed the data and wrote the manuscript. All authors read and approved the manuscript.




Publikationsverlauf

Eingereicht: 11. September 2020

Angenommen: 05. Oktober 2020

Artikel online veröffentlicht:
13. November 2020

© 2020. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Bye AP, Unsworth AJ, Gibbins JM. Platelet signaling: a complex interplay between inhibitory and activatory networks. J Thromb Haemost 2016; 14 (05) 918-930
    CrossrefPubMedGoogle Scholar
  • 2 Shattil SJ, Kim C, Ginsberg MH. The final steps of integrin activation: the end game. Nat Rev Mol Cell Biol 2010; 11 (04) 288-300
    CrossrefPubMedGoogle Scholar
  • 3 Chen J, De S, Damron DS, Chen WS, Hay N, Byzova TV. Impaired platelet responses to thrombin and collagen in AKT-1-deficient mice. Blood 2004; 104 (06) 1703-1710
    CrossrefPubMedGoogle Scholar
  • 4 Woulfe D, Jiang H, Morgans A, Monks R, Birnbaum M, Brass LF. Defects in secretion, aggregation, and thrombus formation in platelets from mice lacking Akt2. J Clin Invest 2004; 113 (03) 441-450
    CrossrefPubMedGoogle Scholar
  • 5 O'Brien KA, Stojanovic-Terpo A, Hay N, Du X. An important role for Akt3 in platelet activation and thrombosis. Blood 2011; 118 (15) 4215-4223
    CrossrefPubMedGoogle Scholar
  • 6 Stalker TJ, Newman DK, Ma P, Wannemacher KM, Brass LF. Platelet signaling. Handb Exp Pharmacol 2012; (210) 59-85
    CrossrefPubMedGoogle Scholar
  • 7 Michelson AD. Platelet function testing in cardiovascular diseases. Hematology 2005; 10 (Suppl. 01) 132-137
    CrossrefPubMedGoogle Scholar
  • 8 Gharehbaghian A, Salimian M, Taherian AA. et al. Variations in intraplatelet phospho-VASP expression due to pre-analytical sample preparations, illustration of a quality control issue in platelet pharmacology. Iran J Pharm Res 2015; 14 (01) 321-328
    PubMedGoogle Scholar
  • 9 Wang H, Ye Y, Wan W. et al. Xinmailong modulates platelet function and inhibits thrombus formation via the platelet αIIbβ3-mediated signaling pathway. Front Pharmacol 2019; 10: 923
    CrossrefPubMedGoogle Scholar
  • 10 Michelson AD. Evaluation of platelet function by flow cytometry. Pathophysiol Haemost Thromb 2006; 35 (1-2): 67-82
    CrossrefPubMedGoogle Scholar
  • 11 Greinacher A, Pecci A, Kunishima S. et al. Diagnosis of inherited platelet disorders on a blood smear: a tool to facilitate worldwide diagnosis of platelet disorders. J Thromb Haemost 2017; 15 (07) 1511-1521
    CrossrefPubMedGoogle Scholar
  • 12 Durrant TN, Hers I. PI3K inhibitors in thrombosis and cardiovascular disease. Clin Transl Med 2020; 9 (01) 8
    CrossrefPubMedGoogle Scholar
  • 13 Stojanovic A, Marjanovic JA, Brovkovych VM. et al. A phosphoinositide 3-kinase-AKT-nitric oxide-cGMP signaling pathway in stimulating platelet secretion and aggregation. J Biol Chem 2006; 281 (24) 16333-16339
    CrossrefPubMedGoogle Scholar